Home > Boards > US Listed > Biotechs > Exact Sciences (EXAS)

EXAS -9% on Taiwanese liquid-biopsy test profiled by

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 739
Posts 112,985
Boards Moderated 16
Alias Born 09/05/02
160x600 placeholder
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/30/2020 9:19:00 AM
Oncotype DX Genomic Prostate Score® Result Shows for the First Time the Value of the Test to Guide Treatment Plans for Unfav... PR Newswire (US) - 6/16/2020 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 6/2/2020 6:08:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/2/2020 6:01:05 AM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 6/1/2020 4:11:07 PM
Exact Sciences Showcases Continued Progress in Cancer Diagnostics at ASCO 2020 PR Newswire (US) - 5/29/2020 8:00:00 AM
Exact Sciences to participate in June investor conferences PR Newswire (US) - 5/26/2020 6:00:00 AM
New Oncotype DX® Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results PR Newswire (US) - 5/14/2020 6:00:00 AM
New Oncotype DX® Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results PR Newswire (US) - 5/14/2020 6:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2020 4:11:26 PM
Exact Sciences Announces First Quarter 2020 Results PR Newswire (US) - 5/6/2020 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2020 4:04:20 PM
New Model Shared at Digestive Disease Week (DDW) Demonstrates the Value of Cologuard® When Using Real-World Adherence Rates ... PR Newswire (US) - 5/5/2020 10:30:00 AM
Exact Sciences to participate in May investor conference PR Newswire (US) - 5/4/2020 6:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2020 4:11:47 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/29/2020 4:10:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/24/2020 4:51:53 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/24/2020 4:48:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/24/2020 8:13:15 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/22/2020 4:19:39 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/22/2020 4:15:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/21/2020 4:33:30 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/17/2020 4:30:30 PM
Exact Sciences schedules first-quarter 2020 earnings call PR Newswire (US) - 4/8/2020 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/6/2020 4:41:56 PM
DewDiligence Member Level  Wednesday, 01/17/18 10:37:44 AM
Re: None
Post # of 609 
EXAS -9% on Taiwanese liquid-biopsy test profiled by ASCO: #msg-137740680.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist